Isolation of a B-cell-specific promoter for the human class II transactivator

Immunogenetics

Volumn 45, Issue 4, 1997, Pages 266-273

  Lennon, Ana Maria ^a   Ottone, Catherine ^a   Rigaud, Gildas ^a   Deaven, Larry L ^b   Longmire, Jon ^b   Fellous, Marc ^a   Bono, Rosa ^c   Alcaïde Loridan, Catherine ^a  

^a INSTITUT PASTEUR   (France)

^b LOS ALAMOS NATIONAL LABORATORY   (United States)

^c UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; LUCIFERASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; BINDING SITE; CONTROLLED STUDY; COSMID; DNA TRANSFECTION; ENZYME ACTIVITY; EPITHELIUM CELL; FIBROSARCOMA; GENE EXPRESSION; GENE INDUCTION; GENE ISOLATION; GENE SEQUENCE; HUMAN; HUMAN CELL; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

B-LYMPHOCYTES; BASE SEQUENCE; CELLS, CULTURED; COSMIDS; DNA; EPITHELIUM; GENES, MHC CLASS II; HUMANS; LUCIFERASES; MACROPHAGES; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS;

ANIMALIA;

EID: 0031054681     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002510050202     Document Type: Article

References (39)

1. Accolla, R. S. Human B cell variants immunoselected against a single Ia antigen subset have lost expression of several Ia antigen subsets. J Exp Med 157: 1053-1058, 1983
2. Bénichou, B. and Strominger, J. L. Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis. Proc Natl Acad Sci USA 88: 4285-4288, 1991
3. Benoist, C. and Mathis, D. The regulation of major histocompatibility complex class II genes: X, Y and other letters of the alphabet. Annu Rev Immunol 8: 681-715, 1990
4. Bono, M. R., Benech, P., Couillin, P., Alcaïde-Loridan, C., Grisard, M.-C., Jouin, H., Fischer, D. G., and Fellous, M. Characterization of human IFN-γ response using somatic cell hybrids of hematopoietic and nonhematopoietic origin. Somat Cell Mol Genet 15: 513-523, 1989
5. Bono, R., Hyafil, F., Kalil, J., Koblar, V., Wiels, J., Wollman, E., and Fellous, M. Monoclonal antibodies against HLA-DRw antigens. Transplant Clin Immunol XI: 109-117, 1979
6. Borles, J.-C., Willerford, D. M., Grévin, D., Davidson, L., Camus, A., Martin, P., Stéhelin, D., and Alt, F. W. Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the ets-1 protooncogene. Nature 377: 635-638, 1995
7. Chang, C.-H., Fontes, J. D., Peterlin, M., and Flavell, R. A. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J Exp Med 180: 1367-1374, 1994
8. Chang, C.-H., Guerder, S., Hong, S.-C., van Ewijk, W., and Flavell, R. A. Mice lacking the MHC class II Transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 4: 167-178, 1996
9. Chang, C. H. and Flavell, R. A. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J Exp Med 181: 765-767, 1995
10. Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., and Rutter, W. J. Isolation of biologically-active ribonucleic acid from sources enriched in ribonuclease. Biochem 18: 5294-5299, 1979
11. Dedrick, R. L. and Jones, P. P. Sequence elements required for activity of a murine histocompatibility complex class II promoter bind common and cell-type-specific nuclear factors. Mol Cell Biol 10: 593-604, 1990
12. Durand, B., Kobr, M., Reith, W., and Mach, B. Functional complementation of major histocompatibility complex class II regulatory mutants by the purified X-box-binding protein RFX. Mol Cell Biol 14: 6839-6847, 1994
13. Evans, G. A., Lewis, K., and Rothenberg, B. E. High efficiency vectors for cosmid microcloning and genomic analysis. Gene 79: 9-20, 1989
14. Gachter, T., Werenskiold, A. K., and Klemenz, R. Transcription of the interleukin-1 receptor-related T1 gene is initiated at different promoters in mast cells and fibroblasts. J Biol Chem 271: 124-129, 1996
15. Germain, R. N. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76: 287-299, 1994
16. Glimcher, L. H. and Kara, C. J. Sequences and factors: a guide to MHC class II transcription. Annu Rev Immunol 10: 13-50, 1992
17. Hume, C. R., Accolla, R. S., and Lee, J. S. Defective HLA class II expression in a regulatory mutant is partially complemented by activated ras oncogenes. Proc Natl Acad Sci USA 84: 8603-8607, 1987
18. Kadonaga, J. T., Jones, K. A., and Tjian, R. Promoter-specific activation of RNA polymerase II transcription by Sp1. Trends Biochem Sci 11: 20-23, 1986
19. Lennon, A. M., Ottone, C., Peijnenburg, A., Hamon-Besnais, C., Colland, F., Gobin, S., van den Elsen, P., Fellous, M., Bono, R., and Alcaïde-Loridan, C. The RAG cell line defines a new group of MHC class II deficiency. Immunogenetics 43: 352-359, 1996
20. Lo, K., Landau, N. R., and Smale, S. T. LyF-1, a transcriptional regulator that interacts with a novel class of promoters for lymphocyte-specific genes. Mol Cell Biol 11: 5229-5243, 1991
21. Panelli, M. C., Wang, E., Shen, S., Schluter, S. F., Bernstein, R. M., Hersh, E. M., Stopeck, A., Gangavalli, R., Barber, J., Jolly, D., and Akporiaye, E. T. Interferon-gamma gene transfer of an EMT6 tumour that is poorly responsive to IFN-gamma stimulation: increase of tumour immunogenicity is accompanied by induction of a mouse class II transactivator and class II MHC. Cancer Immunol Immunother 42: 99-107, 1996
22. Peijnenburg, A., Godthelp, B., van Boxel-Dezaire, A., and van den Elsen, P. J. Definition of a novel complementation group in MHC class II deficiency. Immunogenetics 41: 287-294, 1995
23. Perrotti, D., Melotti, P., Skorski, T., Casella, I., Peschle, C., and Calabretta, B. Overexpression of the zinc finger protein MZF1 inhibits hematopoietic development from embryonic stem cells: correlation with negative regulation of CD34 and c-myb promoter activity. Mol Cell Biol 15: 6075-6087, 1995
24. Quandt, K., Frech, K., Karas, H., Wingender, E., and Werner, T. MatInd and MatInspector. New fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 23: 4878-4884, 1995
25. Rigaud, G., Paiola, F., and Accolla, R. S. In vivo modification of major histocompatibility complex class II DRA promoter occupancy mediated by the AIR-1 trans-activator. Eur J Immunol 2-4: 2415-2420, 1994
26. Riley, J. L., Westerheide, S. D., Price, J. A., Brown, J. A., and Boss, J. M. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity 2: 533-543, 1995
27. Roy, A. L., Meisterernst, M., Pognonec, P., and Roeder, R. G. Cooperative interaction of an initiator-binding transcription initiation factor and the helix-loop-helix activator USF. Nature 354: 245-248, 1991
28. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, 1989
29. Schindler, C. and Darnell, J. E. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem 64: 621-651, 1995
30. Seidel, H. M., Milocco, L. H., Lamb, P., Darnell, J. E., Stein, R. B., and Rosen, J. Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc Natl Acad Sci USA 92: 3041-3045, 1995
31. Silacci, P., Mottet, A., Steimle, V., Reith, W., and Mach, B. Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA. J Exp Med 180: 1329-1336, 1994
32. Smale, S. T. and Baltimore, D. The "initiator" as a transcrition control element. Cell 57: 103-113, 1989
33. Steimle, V., Otten, L. A., Zufferey, M., and Mach, B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or Bare Lymphocyte Syndrome). Cell 75: 135-146, 1993
34. Steimle, V., Durand, B., Barras, E., Zufferey, M., Hadam, M. R., Mach, B., and Reith, W. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev 9: 1021-1032, 1995
35. Steimle, V., Siegrist, C.-A., Mottet, A., Lisowska-Grospierre, B., and Mach, B. Regulation of MHC class II expression by interteron-γ mediated by the transactivator CIITA. Science 265: 106-109, 1994
36. Watson, D. K., McWilliams, M. J., Lapis, P., Lautenberger, J. A., Schweinfest, C. W., and Papas, T. S. Mammalian ets-1 and ets-2 encode highly conserved proteins. Proc Natl Acad Sci USA 85: 7862-7866, 1988
37. Wright, T. M. and Farber, J. M. 5′ regulatory region of a novel cytokine gene mediates selective activation by interferon γ. J Exp Med 173: 417-422, 1991
38. Yamamoto, M., Ko, L. J., Leonard, M. W., Beug, H., Orkin, S. H., and Engel, J. D. Activity and tissue-specific expression of the transcription factors NF-E1 multigene family. Genes Dev 4: 1650-1662, 1990
39. Zhou, H. and Glimcher, L. H. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity 2: 545-553, 1995